In an orthotopic 4T1 model (Fig. 6i), treatment with ADV-ApoA1 significantly suppressed tumor growth and prolonged the survival of tumor-bearing mice, as compared to ADV-Ctr and PBS (Fig. 6j, k). Here, APOA1 is linked to neoplasm.